Contribution of serotonin (5-hydroxytryptamine;: 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine:: Acute and chronic pharmacological analyses

被引:107
|
作者
Filip, M
Bubar, MJ
Cunningham, KA [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
[2] Polish Acad Sci, Inst Pharmacol, Krakow, Poland
关键词
D O I
10.1124/jpet.104.068841
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes (5-HT2A R, 5-HT2B R, and 5-HT2C R) in acute cocaine-evoked hyperactivity was compared with their contribution to the development and expression of locomotor sensitization upon repeated, intermittent treatment with cocaine ( 10 mg/kg/day for 5 days) in male Wistar rats. Cocaine-evoked hyperactivity was significantly enhanced by pretreatment with the preferential 5-HT2A R agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and the 5-HT2C R antagonist SDZ SER-082 [(+)-cis-4,5,7a, 8,9,10,11,11a-octahydro-7H-10-methylindolo(1,7-BC)( 2,6) naphthyridine fumarate]. The 5-HT2A R antagonist SR 46349B [1(Z)-[2-(dimethylamino) ethoxyimino]- 1( 2- fluorophenyl)3-( 4-hydroxyphenyl)-2(E)-propene] and the preferential 5- HT2C R agonist MK 212 [6-chloro-2-(1-piperazinyl) pyrazine HCl] ( 2 mg/kg) significantly attenuated acute cocaine-evoked hyperactivity; however, a lower dose of MK 212 (0.3 mg/kg) enhanced cocaine-evoked hyperactivity. The 5-HT2BR agonist BW 723C86 (1-[5-(2-thienylmethoxy)-1H-3-indolyl] propan-2-amine HCl) and the 5-HT2B R antagonist SB 204741 [N-(1-methyl- 5-indolyl)- N'-(3-methyl-5-isothiazolyl) urea] had no effect on cocaine-evoked hyperactivity. Repeated treatment with cocaine alone resulted in a 2-fold increase in hyperactivity upon challenge with cocaine 5 days after termination of the cocaine regimen (sensitization). The 5-HT2A R antagonist SR 46349B also blocked cocaine-evoked hyperactivity following repeated cocaine treatment, whereas the other 5-HT2R ligands were ineffective. When any of the 5-HT2R ligands was coadministered with cocaine during the treatment regimen ( 10 mg/kg/day for 5 days), the development of sensitization was unchanged as measured by the level of cocaine-evoked hyperactivity upon challenge 5 days after termination of the treatment. The present study implies that 5-HT2AR and 5-HT2CR exert oppositional influence upon hyperactivity evoked by acute administration of cocaine; this balance is altered following repeated cocaine administration.
引用
收藏
页码:1246 / 1254
页数:9
相关论文
共 50 条
  • [21] ANTIHYPERTENSIVE EFFECTS OF CHRONIC 5-HYDROXYTRYPTAMINE (5-HT2) RECEPTOR BLOCKADE WITH KETANSERIN IN THE SPONTANEOUSLY HYPERTENSIVE RAT
    PETTERSSON, A
    PERSSON, B
    HENNING, M
    HEDNER, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (01) : 43 - 47
  • [22] METABOLISM OF 5-HYDROXYTRYPTAMINE (5-HT) BY LIVER
    TYCE, GM
    FLOCK, EV
    OWEN, CA
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 343 - &
  • [23] ADRENERGIC RECEPTORS AND 5-HYDROXYTRYPTAMINE (5-HT)
    PLUCHINO, S
    ACTA CIENTIFICA VENEZOLANA, 1970, 21 : 39 - &
  • [24] RELEASE AND UPTAKE OF 5-HYDROXYTRYPTAMINE (5-HT) BY A SINGLE 5-HT CONTAINING NEURON
    GERSCHENFELD, HM
    HAMON, M
    PAUPARDINTRITSCH, D
    JOURNAL OF PHYSIOLOGY-LONDON, 1976, 260 (02): : P29 - P30
  • [25] Pharmacological characterisation of human 5-HT2 receptor subtypes
    Jerman, JC
    Brough, SJ
    Gager, T
    Wood, M
    Coldwell, MC
    Smart, D
    Middlemiss, DN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 414 (01) : 23 - 30
  • [26] HYPERALGESIC AND HYPOALGESIC EFFECTS OF A 5-HYDROXYTRYPTAMINE (5-HT) AGONIST
    BERGE, OG
    HOLE, K
    DAHLE, H
    ACTA PHYSIOLOGICA SCANDINAVICA, 1980, 109 (03): : A29 - A29
  • [27] CLONING OF THE HUMAN SEROTONIN 5-HT2 AND 5-HT1C RECEPTOR SUBTYPES
    SALTZMAN, AG
    MORSE, B
    WHITMAN, MM
    IVANSHCHENKO, Y
    JAYE, M
    FELDER, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) : 1469 - 1478
  • [28] Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs
    Nagakura, Y
    Kamato, T
    Nishida, A
    Ito, H
    Yamano, M
    Miyata, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (05) : 489 - 498
  • [29] PHARMACOLOGICAL PROFILE OF A NEW POTENT 5-HYDROXYTRYPTAMINE (5-HT2) ALPHA-1-RECEPTOR ANTAGONIST
    SCHRODER, G
    BECKMANN, R
    GERBLING, KP
    LOGE, O
    MAASS, B
    MULLER, B
    SEIDELMANN, D
    SCHNEIDER, HH
    SCHULZ, BG
    STURZEBECHER, CS
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (06): : 765 - 770
  • [30] THE EFFECT OF INHALED 5-HYDROXYTRYPTAMINE (5-HT, SEROTONIN) ON AIRWAY CALIBER IN MAN
    CUSHLEY, MJ
    WEE, LH
    HOLGATE, ST
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (04) : 487 - 490